(3S)-3-((S)-4-amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-4-(((2R,5S,11R,14S,17S,20R,21S,27S,30S)-17-(2-(2-aminophenyl)-2-oxoethyl)-27-(3-aminopropyl)-5-(carboxymethyl)-14-((R)-1-carboxypropan-2-yl)-11-(hydroxymethyl)-2,20-dimethyl-3,6,9,12,15,18,22,25,28,32,33-undecaoxo-19-oxa-1,4,7,10,13,16,23,26,29-nonaazabicyclo[28.2.1]tritriacontan-21-yl)amino)-4-oxobutanoic acid
Daptomycin Impurity 8 is a fully characterized chemical compound used as a reference standard of API Daptomycin. The standard offered is compliant with regulatory guidelines. Daptomycin Impurity 8 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - N/A
Related products
Daptomycin Impurity 33 (Daptomycin beta-isomer diastereomer, Acetate Salt)
M.F. -
M.W. 1620.69; 59.04
CAT# AR-D06105
CAS# NA
Daptomycin Impurity 28 (linear Daptomycin impurity, Acetate Salt)
M.F.
M.W. 1638.71; 59.04
CAT# AR-D06100
CAS# NA
